Mankind Pharma Discontinued
FDA Approved Drugs
Mankind Pharma Discontinued
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 15
- Latest Approval Date Jan 02, 2026
- Data Source FDA
- First Approval Date Feb 02, 2023
Company Overview
Company
Mankind Pharma Discontinued
Country
India
Website
Social Profiles
Company Snapshot
Mankind Pharma Discontinued
208, Okhla Industrial Estate, Phase III, New Delhi - 110020
India
www.mankindpharma.com/ contact@mankindpharma.com View on MapFDA Approved Drug Records ( 15 records )
Drug Name
EXTENDED PHENYTOIN SODIUM
Product Number
1
Dosage Form
-
Strength
100MG EXTENDED
Approval Date
2026-01-02
Active Ingredient
PHENYTOIN SODIUM
Application Number
219773
Product Number
1
Dosage Form
-
Strength
100MG EXTENDED
Approval Date
2026-01-02
Regulatory Status
Discontinued
Drug Name
GLYCOPYRROLATE
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2023-02-27
Active Ingredient
GLYCOPYRROLATE
Application Number
217354
Product Number
1
Dosage Form
-
Strength
0.2MG/ML
Approval Date
2023-02-27
Regulatory Status
Discontinued
Drug Name
LATANOPROST
Product Number
1
Dosage Form
-
Strength
0.005%
Approval Date
2025-12-17
Active Ingredient
LATANOPROST
Application Number
220360
Product Number
1
Dosage Form
-
Strength
0.005%
Approval Date
2025-12-17
Regulatory Status
Discontinued
Drug Name
LEVALBUTEROL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.0103% BASE
Approval Date
2024-10-21
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
218770
Product Number
1
Dosage Form
-
Strength
EQ 0.0103% BASE
Approval Date
2024-10-21
Regulatory Status
Discontinued
Drug Name
LEVALBUTEROL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 0.021% BASE
Approval Date
2024-10-21
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
218770
Product Number
2
Dosage Form
-
Strength
EQ 0.021% BASE
Approval Date
2024-10-21
Regulatory Status
Discontinued
Drug Name
LEVALBUTEROL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 0.042% BASE
Approval Date
2024-10-21
Active Ingredient
LEVALBUTEROL HYDROCHLORIDE
Application Number
218770
Product Number
3
Dosage Form
-
Strength
EQ 0.042% BASE
Approval Date
2024-10-21
Regulatory Status
Discontinued
Drug Name
PANTOPRAZOLE SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2024-04-25
Active Ingredient
PANTOPRAZOLE SODIUM
Application Number
215880
Product Number
2
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2024-04-25
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2025-05-16
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
206603
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2025-05-16
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2025-05-16
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
206603
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2025-05-16
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2025-05-16
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
206603
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2025-05-16
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2025-05-16
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
206603
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2025-05-16
Regulatory Status
Discontinued
Drug Name
SUCCINYLCHOLINE CHLORIDE
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2023-02-02
Active Ingredient
SUCCINYLCHOLINE CHLORIDE
Application Number
216127
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2023-02-02
Regulatory Status
Discontinued
Drug Name
TELMISARTAN AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;40MG
Approval Date
2025-03-03
Active Ingredient
HYDROCHLOROTHIAZIDE; TELMISARTAN
Application Number
218406
Product Number
1
Dosage Form
-
Strength
12.5MG;40MG
Approval Date
2025-03-03
Regulatory Status
Discontinued
Drug Name
TELMISARTAN AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;80MG
Approval Date
2025-03-03
Active Ingredient
HYDROCHLOROTHIAZIDE; TELMISARTAN
Application Number
218406
Product Number
2
Dosage Form
-
Strength
12.5MG;80MG
Approval Date
2025-03-03
Regulatory Status
Discontinued
Drug Name
TELMISARTAN AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;80MG
Approval Date
2025-03-03
Active Ingredient
HYDROCHLOROTHIAZIDE; TELMISARTAN
Application Number
218406
Product Number
3
Dosage Form
-
Strength
25MG;80MG
Approval Date
2025-03-03
Regulatory Status
Discontinued
Drug Status Breakdown
15 total- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
EXTENDED PHENYTOIN SODIUM
Application Number
219773
Product Number
1
Active Ingredient
PHENYTOIN SODIUM
Dosage Form
-
Strength
100MG EXTENDED
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.